GSK announces largest private financial contribution to CIHR’s Team Grants initiative addressing threats to Canadian lung health

[ad_1] GSK is investing $2 million in research to address ongoing, new, and emerging threats to lung health in Canada. Tweet this This investment will help interdisciplinary research teams better…